F Douglas Kling

Affiliations

  • Chief Operating Officer at Newamsterdam Pharma Co N.v. (NAMS), 2025-06-18
  • See Remarks at Matinas Biopharma Holdings Inc. (MTNB), 2017-03-01
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NAMS $19.75 18,109 $357,652.75 44,000 2025-06-16 Filing
NAMS $19.19 81,891 $1,571,488.29 62,109 2025-06-16 Filing
NAMS $0.00 100,000 $0.00 44,000 2025-05-15 Filing
NAMS $0.00 910 $0.00 44,000 2025-04-15 Filing
NAMS $0.00 99,090 $0.00 44,910 2025-04-15 Filing